BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT02924038-completion@plaintrial.com
DTSTAMP:20261028T145629Z
DTSTART;VALUE=DATE:20221231
SUMMARY:A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients
  With WHO Grade II Low-Grade Glioma (LGG) — estimated completion date
DESCRIPTION:Terminated. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT02924038
URL:https://plaintrial.com/trial/NCT02924038
END:VEVENT
END:VCALENDAR